Black patients with triple-negative breast cancer may be less likely to receive immunotherapy than white patients
In recent years, Black patients with triple-negative breast cancer (TNBC) received immunotherapy at significantly lower rates ...
New cancer research breakthrough has the potential to save lives
Pancreatic cancer is one of the deadliest forms, but new research could one day lead to lives being saved. Researchers at UMass Chan Medical School in Worcester discovered that using something called ...
The Navy's highest-ranking military officer is treated successfully for breast cancer
The Navy says its highest-ranking military officer has been successfully treated for early-stage breast cancer ...
Tivozanib has efficacy in advanced renal cell carcinoma post-immune checkpoint inhibitor therapy
For patients with metastatic renal cell carcinoma (mRCC) and progression during or after one to two prior lines of therapy, ...
Mena FN22h
How Critical Demand For Metastatic Breast Cancer Therapies Is Producing A Multi-Billion Dollar Opportunity For Biotechs - Financial News Media
has approved Kisqali® (ribociclib) in combination with an aromatase inhibitor (AI) for the adjuvant treatment of people with hormone receptor-positive/human epidermal growth factor receptor 2-negative ...
TMCnet23h
How Critical Demand for Metastatic Breast Cancer Therapies is Producing a Multi-Billion Dollar Opportunity for Biotechs
FN Media Group News Commentary - Breast cancer is an illness in which the breast cells get uncontrollably large. The type of breast cancer depends on which cells in the breast become cancerous. Cancer ...